< Back to search
Filter
1

Radionecrosis and FDG PET

for
Malignant Glioma
Location: Ottawa
Sponsor: Ottawa Hospital Research Institute

Sex: All

Age: 18+

Code: NCT02391246

Recruiting

Non-invasive Glioma Characterization Through Molecular Imaging

for
Glioma, Brain Tumor, Primary Brain Tumor, Malignant Glioma,
Location: Miami FL
Sponsor: University of Miami

Sex: All

Age: 18+

Code: NCT03684109

Recruiting

STARLITE for Unresectable High-Grade Gliomas

for
High Grade Glioma
Location: Miami FL
Sponsor: University of Miami

Sex: All

Age: 18+

Code: NCT06428045

Phase1, Recruiting

DB107-Retroviral Replicating Vector (RRV) Combined With DB107-Flucytosine (FC) in Patients With Recurrent Glioblastoma or Anaplastic Astrocytoma

for
High Grade Glioma, Anaplastic Astrocytoma
Location: Miami FL
Sponsor: Ashish Shah

Sex: All

Age: 18 - 70+

Code: NCT06264388

Phase2, Recruiting

Magnetic Resonance (MR) Imaging to Determine High Risk Areas in Patients With Malignant Gliomas and to Design Potential Radiation Plans and to Examine Metabolite Changes in Gliomas and Other Solid Tumors

for
Brain Cancer, Glioma
Location: New York NY
Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All

Age: 18+

Code: NCT00870129

Recruiting

Interested in new malignant glioma trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Radiation Therapy, Temozolomide, Tamoxifen, and Carboplatin in Treating Patients With Malignant Gliomas

for
Brain and Central Nervous System Tumors
Location: Encinitas CA
Sponsor: San Diego Pacific Oncology & Hematology Associates

Sex: All

Age: 18+

Code: NCT00492687

Phase2, Recruiting

Treatment of Relapsed/Refractory Intracranial Glioma in Patients Under 22 Years of Age

for
Glioblastoma Multiforme, Anaplastic Astrocytoma,
Location: Miami FL
Sponsor: University of Miami

Sex: All

Age: 1 - 21

Code: NCT05956821

Phase1, Phase2, Recruiting

Dabrafenib and/or Trametinib Rollover Study

for
Melanoma, Non Small Cell Lung Cancer, Solid Tumor, Rare Cancers,
Location: Toronto
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 18 - 70+

Code: NCT03340506

Recruiting

Zr-89 Crefmirlimab Berdoxam and Immuno-Positron Emission Tomography for the Imaging of Patients With Resectable Brain Tumors

for
Glioma, Malignant Brain Neoplasm, Meningioma,
Location: Los Angeles CA
Sponsor: Jonsson Comprehensive Cancer Center

Sex: All

Age: 18+

Code: NCT06650163

Phase1, Recruiting

Spectroscopic MRI, Proton Therapy, and Avastin for Recurrent Glioblastoma

for
Recurrent Glioblastoma
Location: Miami FL
Sponsor: University of Miami

Sex: All

Age: 18+

Code: NCT05284643

Recruiting

Biologic Association Between Metabolic Magnetic Resonance-positron Emission Tomograph (MR-PET) and Tissue Measures of Glycolysis in Brain Tumors of Infiltrating Glioblastoma Cells

for
Glioblastoma Multiforme, Glycolytic Index,
Location: Los Angeles CA
Sponsor: Jonsson Comprehensive Cancer Center

Sex: All

Age: 18+

Code: NCT06059690

Phase1, Phase2, Recruiting

Autologous CAR-T Cells Targeting B7-H3 in Recurrent or Refractory GBM CAR.B7-H3Tc

for
Glioblastoma Multiforme
Location: Chapel Hill NC
Sponsor: UNC Lineberger Comprehensive Cancer Center

Sex: All

Age: 18+

Code: NCT05366179

Phase1, Recruiting

BGB-58067 in Newly Diagnosed Glioblastoma Patients With MTAP-Deleted Tumors

for
Glioblastoma (GBM)
Location: Phoenix AZ
Sponsor: Nader Sanai

Sex: All

Age: 18+

Code: NCT07485049

Early_phase1, Recruiting

A Phase 0/1 Clinical Trial With an Expansion Phase of GSK5764227, a B7-H3-Targeted Antibody-Drug Conjugate (ADC), in Patients With Recurrent Grade 4 Glioma and Patients With Brain Metastases

for
Glioblastoma (GBM), Brain Metastasases
Location: Phoenix AZ
Sponsor: Nader Sanai

Sex: All

Age: 18+

Code: NCT07268053

Early_phase1, Recruiting

Imaging Acetadote Metabolism in Glioblastoma

for
Glioblastoma, GBM
Location: Dallas TX
Sponsor: University of Texas Southwestern Medical Center

Sex: All

Age: 18+

Code: NCT07387666

Early_phase1, Recruiting

ERAS-801 for the Treatment of Resectable and Progressive or Recurrent or Elderly Newly Diagnosed IDH Wildtype Grade IV Glioblastoma or Gliosarcoma With an EGFR Amplification or Mutation, ERAS801-SARG Trial

for
Glioblastoma, Glioblastoma, IDH-Wildtype, Gliosarcoma,
Location: Los Angeles CA
Sponsor: Jonsson Comprehensive Cancer Center

Sex: All

Age: 18+

Code: NCT07089641

Phase1, Recruiting

PH Sensitive MRI Based Resections of Glioblastoma

for
Glioblastoma
Location: Los Angeles CA
Sponsor: University of California, Los Angeles

Sex: All

Age: 18+

Code: NCT06176066

Phase1, Recruiting

Advanced Imaging Techniques for Evaluating the Tumor Immune Microenvironment in Glioblastoma Patients

for
Glioblastoma
Location: Los Angeles CA
Sponsor: Jonsson Comprehensive Cancer Center

Sex: All

Age: 18+

Code: NCT07461948

Phase3, Recruiting

Clinical Trial of BMS-986504 in Recurrent GBM Patients

for
Glioblastoma WHO Grade IV
Location: Phoenix AZ
Sponsor: Nader Sanai

Sex: All

Age: 18+

Code: NCT06883747

Early_phase1, Recruiting

Magnetic Resonance Imaging for Improving Knowledge of Brain Tumor Biology in Patients With Resectable Glioblastoma

for
Glioblastoma, Recurrent Glioblastoma, Resectable Glioblastoma
Location: Los Angeles CA
Sponsor: Jonsson Comprehensive Cancer Center

Sex: All

Age: 18+

Code: NCT06090903

Recruiting